Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 77 clinical trials
TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma

The objective of this study is to evaluate the efficacy and safety of transcatheter arterial chemoembolization combined with anti-pd-1 antibody in patients with advanced hepatocellular carcinoma

sintilimab
antiviral therapy
neutrophil count
ct scan
renal function
  • 0 views
  • 16 Jun, 2022
  • 1 location
PD-1 Antibody and Lenvatinib Plus TACE on Downstaging BCLC B/C HCC

The purpose of this study is to assess the difference of safety and efficacy about PD-1 Antibody and Lenvatinib Plus transcatheter arterial chemoembolization (TACE) on downstaging hepatocellular

TACE
  • 0 views
  • 30 Jul, 2021
  • 1 location
Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC

chemoembolization(TACE) in patients with middle-advanced hepatocellular carcinoma(HCC)

liver cancer
cancer
angiogenesis inhibitor
chemoembolization
cabozantinib
  • 1 views
  • 20 Feb, 2022
  • 1 location
Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma

Hepatocellular carcinoma is the third most common cause of cancer-related mortality. In recent years, transarterial chemoembolization, radio frequency ablation and microwave ablation have been

chemoembolization
unresectable hepatocellular carcinoma
hepatocellular carcinoma
carcinoma
TACE
  • 6 views
  • 22 Jan, 2021
  • 1 location
Tislelizumab in Addition to BACE in Patients With NSCLC

This is a single-arm phase II trial to determine the efficacy and safety of Tislelizumab in addition to bronchial arterial chemoembolization in stage III-Ⅳ NSCLC patients who failed, refused or

cancer chemotherapy
chemoradiotherapy
  • 0 views
  • 21 Mar, 2022
  • 1 location
TACE Combined With Sintilimab Plus Bevacizumab Biosimilar in Hepatocellular Carcinoma (BCLC-C Stage ): a Prospective Single-arm Phase II Clinical Study

The purpose of this study is to evaluate the efficacy and safety of transcatheter arterial chemoembolization (TACE) combined with pd-1 antibody immunotherapy (Sintilimab) and anti-VEGF

ct scan
cancer
TACE
  • 0 views
  • 03 Oct, 2021
  • 1 location
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random Controlled Stage III Clinical Trial.

To compare the impact on recurrence risk of adjuvant TAI and adjuvant TACE for patients with HCC and PVTT after hepatectomy.

tumor thrombosis
hepatectomy
thrombosis
fluorouracil
chemoembolization
  • 8 views
  • 21 Jan, 2021
Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/Bevacizumab (DEMAND)

Aim of the study is to evaluate the efficacy of up-front atezolizumab/ bevacizumab (Atezo/Bev) followed by on-demand selective transarterial chemoembolization (sdTACE) and of initial synchronous

chemoembolization
TACE
  • 6 views
  • 04 Mar, 2022
  • 5 locations
Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma

This is a phase 2 single-arm, open-label clinical trial determining efficacy of cabozantinib in combination with ipilimumab/nivolumab and transarterial chemoembolization (TACE) in subjects with

nivolumab
TACE
cabozantinib
chemoembolization
measurable disease
  • 0 views
  • 19 Apr, 2022
  • 1 location
TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT

This study is conducted to evaluate the efficacy and safety of transarterial chemoembolization (TACE) combined with sorafenib/lenvatinib and iodion-125 seeds brachytherapy (TACE-MKI-I) compared

  • 0 views
  • 13 Aug, 2021
  • 1 location